Health Economics and Policy

Gene and stem cell therapies hold the promise of restoring vision in patients with retinal diseases – but who should be paying for these treatments, and how?

We look at the last 50 years of Fight for Sight – the projects it has funded, and the discoveries its funding helped to achieve.

Ophthalmologists and other eye health stakeholders lobby UK Parliament to implement improved sight loss and eye health services

Italy reimburses off-label bevacizumab use in ophthalmology – pharma complains to the European Commission.

New testing methods could help eliminate the neglected tropical disease

Peek Retina is an adaptor for your smartphone that promises easy and high-quality fundoscopy – no matter if you’re in Scotland or sub-Saharan Africa

An overstretched UK hospital that subcontracted cataract surgery is faced with a 48.3 percent complication rate. Who foots the legal bill?

Popular culture has always viewed eyes as being things of beauty. But there’s more to the eye than the color of your irides.

Dramatic improvements in the results from an astigmatic keratotomy model suggest that the femtosecond laser may be more than a rich ophthalmologist’s toy after all.

With childhood vision disorders like amblyopia and strabismus, early diagnosis is the key to treatment success.